Beijing Surgerii Robotics Co., Ltd.

Surgerii Robotics® focuses on the field of precise minimally invasive medicine and is a high-tech enterprise with full-chain independent core intellectual property rights and original core technologies.
With its self-developed next-generation deformable continuum core technology, Surgerii Robotics® has successfully completed the R&D and industrialization of the single-port snake-arm endoscopic surgical robot. As China’s first domestically developed single-port endoscopic surgical system, the product has been approved for clinical application in multiple departments, including Urology, Gynecology, General Surgery and Thoracic Surgery. Featuring ultra-minimally invasive and high-precision clinical advantages, it enables more accurate surgery, less surgical trauma and faster patient recovery.
In August 2025, the surgical robot officially obtained EU CE certification, becoming the first Chinese surgical robot approved for all patient groups across the EU and accelerating the global layout of China’s precision medical technology.